Ataxia Treatment Market Share

On the basis of geographical analysis, the global ataxia treatment market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and the Middle East & Africa region. Asia Pacific is expected to hold largest revenue share by 2036, on the back of increase in patient pool with genetic strains of ataxia, rising levels of awareness associated with the disease, and government initiatives to curb neurodegenerative disorders. As per the data provided by Centers for Medicare and Medicaid Services, U.S. health care spending grew 4.6 percent in 2019, reaching $3.8 trillion or $11,582 per person.  As a share of the nation's Gross Domestic Product, health spending accounted for 17.7 percent. Moreover, the market in North America is anticipated to grab the largest share by the end of the forecast period, which can be ascribed to the high occurrence of ataxia, establishment of several support organizations for patient diagnosis and treatment, and growing government healthcare spending in the region. In addition, strong presence of prominent market players is also expected to boost the region’s market growth in the coming years.